Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization

2018 ◽  
Vol 37 (9) ◽  
pp. 2415-2421 ◽  
Author(s):  
Sang-Cheol Bae ◽  
Young Ho Lee
2007 ◽  
Vol 67 (4) ◽  
pp. 530-535 ◽  
Author(s):  
K H Costenbader ◽  
D Feskanich ◽  
M Holmes ◽  
E W Karlson ◽  
E Benito-Garcia

Objectives:Vitamin D has immune-modulating effects and may protect against the development of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).Methods:We identified incident cases of SLE and RA among 186 389 women followed from 1980 to 2002 in the Nurses’ Health Study and Nurses’ Health Study II cohorts. We excluded subjects where SLE or RA was not confirmed by medical record review, and those who failed to return questionnaires. Semi-quantitative food frequency questionnaires assessed vitamin D intake from food and supplements. We used cumulative-updated total energy-adjusted dietary exposures for each 2-year cycle. Relationships between vitamin D intake and incident SLE and RA were examined in age-adjusted and Cox proportional hazards models, adjusted for confounders. Results were pooled using meta-analysis random effects models.Results:We confirmed 190 incident cases of SLE and 722 of RA with dietary information. Increasing levels of vitamin D intake had no relationship to the relative risk of developing either SLE or RA.Conclusions:Vitamin D intake was not associated with risk of SLE or RA in these large prospective cohorts of women.


Lupus ◽  
2020 ◽  
Vol 29 (4) ◽  
pp. 364-370
Author(s):  
W -t Zhang ◽  
T -f Jin ◽  
L Chen

Associations of polymorphisms in vitamin D receptor ( VDR) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have already been explored by many studies. The aim of this meta-analysis was to better clarify associations between polymorphisms in VDR and RA/SLE by combing the results of all relevant studies. Eligible studies were searched from Pubmed, Embase, WOS and CNKI. We used Review Manager to combine the results of eligible studies. Thirty-seven studies were included in this meta-analysis. VDR rs1544410 (recessive comparison: odds ratio (OR) = 1.36, 95% confidence interval (CI) 1.06–1.76; over-dominant comparison: OR = 0.81, 95% CI 0.71–0.93) and rs731236 (over-dominant comparison: OR = 0.77, 95% CI 0.63–0.94) polymorphisms were found to be significantly associated with RA in overall combined analyses. Besides, VDR rs1544410 (dominant comparison: OR = 0.61, 95% CI 0.46–0.82; over-dominant comparison: OR = 1.45, 95% CI 1.16–1.81; allele comparison: OR = 0.75, 95% CI 0.62–0.92), rs2228570 (dominant comparison: OR = 0.58, 95% CI 0.50–0.67; recessive comparison: OR = 1.57, 95% CI 1.21–2.03; allele comparison: OR = 0.69, 95% CI 0.60–0.80) and rs731236 (dominant comparison: OR = 0.69, 95% CI 0.50–0.96; allele comparison: OR = 0.80, 95% CI 0.70–0.90) polymorphisms were also found to be significantly associated with SLE in overall combined analyses. Subgroup analyses revealed that significant associations for VDR polymorphisms and RA/SLE were mainly driven by Asians. Collectively, this meta-analysis proved that VDR rs7975232, rs1544410, rs2228570 and rs731236 polymorphisms may confer susceptibility to RA and SLE, especially for Asians.


2014 ◽  
Author(s):  
Cristina Vergara ◽  
Angels Martinez-Ferrer ◽  
Elvira Vicens ◽  
Elia Valls ◽  
Jose Oller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document